Aaron Nguyen

1.4k total citations
21 papers, 966 citations indexed

About

Aaron Nguyen is a scholar working on Molecular Biology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Aaron Nguyen has authored 21 papers receiving a total of 966 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Hematology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Aaron Nguyen's work include Acute Myeloid Leukemia Research (5 papers), Melanoma and MAPK Pathways (5 papers) and Multiple Myeloma Research and Treatments (4 papers). Aaron Nguyen is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Melanoma and MAPK Pathways (5 papers) and Multiple Myeloma Research and Treatments (4 papers). Aaron Nguyen collaborates with scholars based in United States, United Kingdom and Spain. Aaron Nguyen's co-authors include Kazuhiro Shiozaki, Albert Lee, Kyle J. MacBeth, Carla Heise, Sharon L. Aukerman, Leslie A. Krushel, Helen Brady, Michelle M. Williams, Paul W. Hollenbach and Yuhong Ning and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and PLoS ONE.

In The Last Decade

Aaron Nguyen

21 papers receiving 949 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aaron Nguyen United States 12 695 421 207 80 79 21 966
Jake Delmore United States 17 614 0.9× 332 0.8× 367 1.8× 86 1.1× 43 0.5× 32 967
Mariël Brok Netherlands 13 531 0.8× 232 0.6× 323 1.6× 28 0.3× 154 1.9× 14 951
Tracy Keates United Kingdom 7 1.6k 2.3× 496 1.2× 222 1.1× 57 0.7× 20 0.3× 7 1.7k
Shannon C. Dixon United States 14 452 0.7× 188 0.4× 216 1.0× 115 1.4× 56 0.7× 18 844
Kate E. Jarman Australia 13 499 0.7× 220 0.5× 157 0.8× 106 1.3× 70 0.9× 24 870
Heriberto Bruzzoni‐Giovanelli France 15 570 0.8× 179 0.4× 281 1.4× 145 1.8× 120 1.5× 23 932
Celia Sigua United States 9 738 1.1× 266 0.6× 143 0.7× 152 1.9× 91 1.2× 15 948
Irma M. Grossi United States 20 598 0.9× 278 0.7× 226 1.1× 89 1.1× 31 0.4× 26 1.3k
Petri Pölönen Finland 14 543 0.8× 146 0.3× 173 0.8× 117 1.5× 51 0.6× 23 792
Teresa A. McCormack Ireland 10 742 1.1× 175 0.4× 293 1.4× 136 1.7× 36 0.5× 10 1.0k

Countries citing papers authored by Aaron Nguyen

Since Specialization
Citations

This map shows the geographic impact of Aaron Nguyen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron Nguyen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron Nguyen more than expected).

Fields of papers citing papers by Aaron Nguyen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron Nguyen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron Nguyen. The network helps show where Aaron Nguyen may publish in the future.

Co-authorship network of co-authors of Aaron Nguyen

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron Nguyen. A scholar is included among the top collaborators of Aaron Nguyen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron Nguyen. Aaron Nguyen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Greil, Richard, Alessandra Tedeschi, Carol Moreno, et al.. (2021). Pretreatment with ibrutinib reduces cytokine secretion and limits the risk of obinutuzumab-induced infusion-related reactions in patients with CLL: analysis from the iLLUMINATE study. Annals of Hematology. 100(7). 1733–1742. 9 indexed citations
3.
4.
Nguyen, Aaron, et al.. (2021). Fuzzy Logic Based MPT Algorithm for Reconfigurable Photovoltaics. 356–359. 1 indexed citations
5.
Dofe, Jaya, Aaron Nguyen, & Andy Nguyễn. (2021). Unified Countermeasures against Physical Attacks in Internet of Things - A survey. 3 indexed citations
6.
Hoff, Daniel D. Von, Drew Rasco, Elisabeth I. Heath, et al.. (2018). Phase I Study of CC-486 Alone and in Combination with Carboplatin or nab-Paclitaxel in Patients with Relapsed or Refractory Solid Tumors. Clinical Cancer Research. 24(17). 4072–4080. 27 indexed citations
7.
Leung, Kevin, Aaron Nguyen, Tao Shi, et al.. (2018). Multiomics of azacitidine-treated AML cells reveals variable and convergent targets that remodel the cell-surface proteome. Proceedings of the National Academy of Sciences. 116(2). 695–700. 42 indexed citations
8.
Therrien, Éric, Natalie Nguyen, Jubrail Rahil, et al.. (2015). Discovery of bicyclic pyrazoles as class III histone deacetylase SIRT1 and SIRT2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(12). 2514–2518. 23 indexed citations
9.
Hollenbach, Paul W., Aaron Nguyen, Helen Brady, et al.. (2010). A Comparison of Azacitidine and Decitabine Activities in Acute Myeloid Leukemia Cell Lines. PLoS ONE. 5(2). e9001–e9001. 288 indexed citations
10.
Medicherla, Satyanarayana, Mamatha Reddy, Ying Jing, et al.. (2009). p38alpha-selective MAP kinase inhibitor reduces tumor growth in mouse xenograft models of multiple myeloma.. PubMed. 28(6A). 3827–33. 21 indexed citations
11.
Navas, Tony, Li Zhou, Myka L. Estes, et al.. (2008). Inhibition of p38α MAPK disrupts the pathological loop of proinflammatory factor production in the myelodysplastic syndrome bone marrow microenvironment. Leukemia & lymphoma. 49(10). 1963–1975. 28 indexed citations
12.
Koppelman, Bruce, Heather K. Webb, Satyanarayana Medicherla, et al.. (2008). Pharmacological Properties of SD-282 – An α-Isoform Selective Inhibitor for p38 MAP Kinase. Pharmacology. 81(3). 204–220. 9 indexed citations
13.
Nguyen, Aaron, Elizabeth G. Stebbins, Margaret Henson, et al.. (2006). Normalizing the bone marrow microenvironment with p38 inhibitor reduces multiple myeloma cell proliferation and adhesion and suppresses osteoclast formation. Experimental Cell Research. 312(10). 1909–1923. 49 indexed citations
14.
Navas, Tony, Mani Mohindru, Myka L. Estes, et al.. (2006). Inhibition of overactivated p38 MAPK can restore hematopoiesis in myelodysplastic syndrome progenitors. Blood. 108(13). 4170–4177. 99 indexed citations
15.
Hideshima, Teru, Klaus Podar, Dharminder Chauhan, et al.. (2004). p38 MAPK inhibition enhances PS-341 (bortezomib)-induced cytotoxicity against multiple myeloma cells. Oncogene. 23(54). 8766–8776. 105 indexed citations
16.
Hayashi, Toshiaki, Teru Hideshima, Aaron Nguyen, et al.. (2004). Transforming Growth Factor β Receptor I Kinase Inhibitor Down-Regulates Cytokine Secretion and Multiple Myeloma Cell Growth in the Bone Marrow Microenvironment. Clinical Cancer Research. 10(22). 7540–7546. 82 indexed citations
17.
Hideshima, Teru, Klaus Podar, Dharminder Chauhan, et al.. (2004). P38 MAPK Inhibition Enhances PS-341 (bortezomib)-Induced Cytotoxicity Against Multiple Myeloma Cells.. Blood. 104(11). 3348–3348. 5 indexed citations
18.
19.
Nguyen, Aaron, et al.. (2002). Cytoplasmic Localization of Wis1 MAPKK by Nuclear Export Signal Is Important for Nuclear Targeting of Spc1/Sty1 MAPK in Fission Yeast. Molecular Biology of the Cell. 13(8). 2651–2663. 31 indexed citations
20.
Nguyen, Aaron, et al.. (2000). Multistep Phosphorelay Proteins Transmit Oxidative Stress Signals to the Fission Yeast Stress-activated Protein Kinase. Molecular Biology of the Cell. 11(4). 1169–1181. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jake Delmore Breakdown of academic impact, for papers by Mariël Brok Breakdown of academic impact, for papers by Tracy Keates Breakdown of academic impact, for papers by Shannon C. Dixon Breakdown of academic impact, for papers by Kate E. Jarman Breakdown of academic impact, for papers by Heriberto Bruzzoni‐Giovanelli Breakdown of academic impact, for papers by Celia Sigua Breakdown of academic impact, for papers by Irma M. Grossi Breakdown of academic impact, for papers by Petri Pölönen Breakdown of academic impact, for papers by Teresa A. McCormack
Rankless by CCL
2026